Head-to-head · WeighScore
Bodybuilding Health+ vs NexLife
By GLP-1 ScorecardUpdated
Score comparison
Bodybuilding Health+ has the higher recorded score — 78.1/100 to 61.9/100.
Bodybuilding Health+ grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodybuilding Health+ advertises compounded injections and several bundle lengths, but its semaglutide and three-month tirzepatide prices differ across pages. Confirm the actual initial payment, renewal price and unused-prepayment terms before choosing a commitment.
Before you choose
Before comparing the headline prices, the Bodybuilding Health+ review and the NexLife review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Bodybuilding Health+ vs Nova MD and CoreAge Rx vs NexLife compare each of them with another graded program, and the list of alternatives to Bodybuilding Health+ ranks the programs closest to Bodybuilding Health+ on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bodybuilding Health+ | NexLife |
|---|---|---|
| WeighScore | 78.1/100 | 61.9/100 |
| Grade | C+ | C |
| Site position | #31 | #304 |
| Semaglutide | $129 one-month product listing; $179 first-month program offer (public pages conflict; renewal unconfirmed; multi-month bundles quoted separately) | $165/mo (compounded) |
| Tirzepatide | $209 one-month listing / first-month offer (renewal unconfirmed; three-month quote conflicts: $179 vs $286/mo) | $215/mo (compounded) |
| Coverage | Advertises all 50 states with service/licensure restrictions; terms say certain states—confirm medication and address | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #31 · C+
Strengths
- Public pages show one-, three-, six- and twelve-month tiers, with advertised bundle totals available for comparison
- Homepage FAQ names Lion MD and four potential pharmacy partners; assignment still needs confirmation
- Tirzepatide product advertises the same price at every dose and no membership fees; confirm the applicable dose range and invoice
- Terms distinguish the Dynamo Group platform from independent clinical and pharmacy providers
What to consider
- Semaglutide product displays $129/$199 for one month while the program advertises $179 first month/$279; recurring price remains unconfirmed
- Three-month tirzepatide differs between the homepage $179/mo ($537 total) and program treatment card $286/mo; twelve-month Best Value allocation also exceeds six-month allocation
- Cancel-anytime FAQ does not explain unused prepaid refunds; terms make consultations nonrefundable after the visit and prescription sales final
- Oral microdosing appears only as a broad FAQ claim without a verified formulation, price or state availability; individual clinician, pharmacy and lab requirements need confirmation
FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
What to consider
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
- FDA issued Nexlife Inc. dba Nexlife a warning letter in June 2026; the letter is public in FDA's warning-letter database
Featured provider
Bodybuilding Health+
Bodybuilding Health+ scores 78.1/100 (C+). Bodybuilding Health+ advertises compounded injections and several bundle lengths, but its semaglutide and three-month tirzepatide prices differ across pages. Confirm the actual initial payment, renewal price and unused-prepayment terms before choosing a commitment.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.